| Literature DB >> 31360635 |
M Deming1,2, A Mark3, V Nyemba1,2, E L Heil4, R M Palmeiro2, S A Schmalzle1,2,3.
Abstract
Cryptococcal meningitis is a potentially devastating infectious complication of immunosuppression best characterized in individuals with HIV. Early recognition of and appropriate antifungal therapy for cryptococcal meningitis has a profound effect on outcomes, but with more varied presentations in well-resourced countries recognition may be delayed. We present four cases of cryptococcal meningitis in immunosuppressed patients, each with significant delays in diagnosis. Pulling from recollections of providers and the documented chart assessments, we discuss and tabulate the cognitive biases and diagnostic errors that contributed to delay. We further explore the knowledge deficits regarding cryptococcal meningitis that appeared in these cases. Once meningitis was considered, each of these cases of cryptococcal meningitis was rapidly diagnosed. Diagnostic delay was driven by knowledge deficits, followed by common biases such as availability heuristics and premature closing. These delays could be countered by maintaining broad differential diagnoses, re-evaluating the patient presentation after recognition of immunosuppression, and early consultation of specialists. Delay in diagnosis of cryptococcal meningitis is associated with high morbidity and mortality. By exploring the various case presentations and errors made, we hope to provide a counter to some of the knowledge deficits associated with cryptococcal meningitis, and to provide actionable advice for early consultation to infectious disease specialists in order to improve outcomes.Entities:
Keywords: Bias; Cryptococcal meningitis; Cryptococcus; Diagnostic error; Heuristic
Year: 2019 PMID: 31360635 PMCID: PMC6639654 DOI: 10.1016/j.idcr.2019.e00588
Source DB: PubMed Journal: IDCases ISSN: 2214-2509
Heuristics contributing to delayed diagnoses of CM.
| Case #1 | Case #2 | Case #3 | Case #4 | |
|---|---|---|---|---|
| 33 y.o. M | 42 y.o. F | 61 y.o M | 70 y.o. M | |
| Availability heuristic | ||||
| Delayed HIV diagnosis | Delayed HIV diagnosis | Rituximab, treated for community acquired then hospital acquired pneumonia | Cyclophosphamide was discontinued prior to second admission | |
| Migraine, musculoskeletal strain, and gastritis. | Urinary tract infection | Pneumonia | Pneumonia and stroke. | |
| Anchoring | ||||
| History of manual labor noted and neck pain attributed to musculoskeletal injury. | Pneumonia diagnosed by imaging. | Altered mental status and stroke noted on MRI. Location inconsistent, but no further evaluation for aphasia | ||
| Subjective initial improvement in headache with migraine treatment, no additional workup or treatment. | New urinary retention & tachycardia considered to be due to "noninfectious cystitis" despite dizziness, fall, and elevated ESR. | Subjective improvement, but no improvement in hypoxia with pneumonia treatment | ||
| Framing | ||||
| Prior diagnosis of migraine noted on admission, additional diagnoses added (gastritis, muscle strain) to migraine rather than re-evaluating. | Bipolar, reported her "nerves were acting up", "difficult to interview" | Retained pneumonia diagnosis despite failure to improve on therapy, lack of cough, inconsistency of blurry vision. | Admitted from nursing home with presumed poor baseline. |
Knowledge deficits associated with delayed diagnoses or improper treatment of CM.
| Common Knowledge Deficit | Correct Approach |
|---|---|
| Cryptococcosis Diagnosis and Management | |
| Fear of adverse drug reactions leading to use of less effective therapies (Case 3) | Combination of AMB and 5-Flucytosine is associated with lower mortality rates than alternate therapies [ |
| Reflexive use of empiric echinocandin when serious fungal infection is suspected (Case 3) | Echinocandins are appropriate for most Candidemia, but not recommended for treatment of Cryptococcosis due to intrinsic resistance [ |
| Delayed initial LP (Case 1,2,3 4), and reluctance to perform repeat therapeutic LP due to perceived lack of necessity (Case 3) | Early and repeat therapeutic LP decreases morbidity and mortality in CM [ |
| Reluctance to perform therapeutic LP due to concern for cerebral herniation (Case 3) | LP is recommended for management of increased ICP for CM in the absence of space occupying lesion on CNS imaging [ |
| Failure to test for or consider undiagnosed HIV with OI in high prevalence settings (Case 1,2) | Routine opt-out testing is recommended over risk-based testing due to earlier and increased diagnosis of HIV [ |
| Failure to consider other sites of Cryptococcal infection in immunocompromised hosts (Case 3, 4) | Cryptococcus species enter via inhalation (pulmonary) and can then disseminate (fungemia) to other body sites (cutaneous, skeletal, urogenital, ocular, hepatic, etc.) [ |
| General Infectious Disease Diagnosis and Management | |
| Assumption that all PNA is typical bacteria (fungal, viral, or atypical bacteria often missed) (Case 3, 4), or assuming altered mental status is sepsis related rather than CNS process (Case 2,3). | Maintain broad differential diagnosis and test and treat as appropriate based on pretest probability of each. Obtain comprehensive samples for culture and microbiological analysis at initiation and escalation of therapy to direct treatment rather than relying on empiric therapy. |
| Consider atypical or opportunistic infections (OIs) in people living with HIV (Case 1,2) or other immunocompromised patients (Case 3, 4) | Consider broadening differential after recognition of immunosuppression, rather than limiting therapy to reflexive institution-specific ‘broad spectrum’ antibacterials for covering any infection |
| Failure to involve ID early in serious infections (Case 1, 2, 3, 4) | ID consults decrease mortality in certain infections [ |
CM = cryptococcal meningitis; AMB = liposomal amphotericin B; LP = lumbar puncture; ICP = intracranial pressure; PNA = pneumonia; OI = opportunistic infection.